Current issue Volume 6(4); October 2024
- Sodium-glucose cotransporter 2 inhibitors in cardiocerebrovascular disease Jin Joo Park Cardiovasc Prev Pharmacother. 2024;6(4):103-108. Review ArticleOctober 31, 2024
- Moyamoya disease: insights into the clinical implications of the RNF213 gene Taedong Ok Cardiovasc Prev Pharmacother. 2024;6(4):109-115. Review ArticleOctober 31, 2024
- Paradigm shift from glucocentric to organ protection for the management of hyperglycemia in patients with type 2 diabetes Jie-Eun Lee, Jong Chul Won Cardiovasc Prev Pharmacother. 2024;6(4):116-122. Review ArticleOctober 31, 2024
- Relationship between autonomic and peripheral neuropathies and cardiovascular outcomes in diabetes Jae-Seung Yun Cardiovasc Prev Pharmacother. 2024;6(4):123-127. Review ArticleOctober 31, 2024
- Use of dual-energy x-ray absorptiometry for body composition in chronic disease management Tae Nyun Kim Cardiovasc Prev Pharmacother. 2024;6(4):128-134. Review ArticleOctober 31, 2024
- Review ArticleOct 31, 2024 Sodium-glucose cotransporter 2 inhibitors in cardiocerebrovascular disease Jin Joo Park Cardiovasc Prev Pharmacother. 2024;6(4):103-108.
- Review ArticleOct 31, 2024 Moyamoya disease: insights into the clinical implications of the RNF213 gene Taedong Ok Cardiovasc Prev Pharmacother. 2024;6(4):109-115.
- Review ArticleOct 31, 2024 Paradigm shift from glucocentric to organ protection for the management of hyperglycemia in patients with type 2 diabetes Jie-Eun Lee, Jong Chul Won Cardiovasc Prev Pharmacother. 2024;6(4):116-122.
- Review ArticleOct 31, 2024 Relationship between autonomic and peripheral neuropathies and cardiovascular outcomes in diabetes Jae-Seung Yun Cardiovasc Prev Pharmacother. 2024;6(4):123-127.
- Review ArticleOct 31, 2024 Use of dual-energy x-ray absorptiometry for body composition in chronic disease management Tae Nyun Kim Cardiovasc Prev Pharmacother. 2024;6(4):128-134.
- MOST VIEWED
- MOST CITED
- Cardiovascular Prevention and Pharmacotherapy
- ENDNOTE STYLE FILE METRICS